Creative Planning’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Creative Planning’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,905	Closed	-$724K	–	2135
2019 Q3	$724K	Buy	+10,905	New	+$732K	﹤0.01%	891
2019 Q2	–	Sell	-33,175	Closed	-$3.71M	–	2148
2019 Q1	$3.71M	Buy	+33,175	New	+$3.62M	0.01%	326
2018 Q4	–	Sell	-2,700	Closed	-$341K	–	2149
2018 Q3	$341K	Sell	2,700 -1,040	-28%	-$110K	﹤0.01%	1313
2018 Q2	$314K	Buy	+3,740	New	+$274K	﹤0.01%	1346
2017 Q4	–	Sell	-9,820	Closed	-$570K	–	2026
2017 Q3	$570K	Buy	9,820 +6,770	+222%	+$729K	﹤0.01%	983
2017 Q2	$369K	Sell	3,050 -1,577	-34%	-$183K	﹤0.01%	1176
2017 Q1	$523K	Buy	4,627 +775	+20%	+$90.5K	﹤0.01%	965
2016 Q4	$419K	Sell	3,852 -883	-19%	-$105K	﹤0.01%	1015
2016 Q3	$779K	Buy	4,735 +1,994	+73%	+$314K	0.01%	694
2016 Q2	$391K	Buy	2,741 +6	+0.2%	+$875	﹤0.01%	906
2016 Q1	$351K	Buy	2,735 +2,108	+336%	+$249K	﹤0.01%	906
2015 Q4	$94K	Sell	627 -3,373	-84%	-$571K	﹤0.01%	1672
2015 Q3	$663K	Buy	+4,000	New	+$880K	0.01%	627
2015 Q2	–	Sell	-180	Closed	-$51K	–	3217
2015 Q1	$51K	Buy	180 +100	+125%	+$21.7K	﹤0.01%	2024
2014 Q4	$12K	Buy	80 +30	+60%	+$5.54K	﹤0.01%	3031
2014 Q3	$12K	Buy	+50	New	+$12.7K	﹤0.01%	2863

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Creative Planning's ICPT Position: Q4 2019 in Review

Creative Planning sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2019, closing a stake of 10,905 shares — an estimated $724K sold.

Creative Planning first reported a position in ICPT in Q3 2014 and held it in 16 quarters. The position peaked at $3.71M in Q1 2019. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

Creative Planning reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Creative Planning sold 10,905 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $724K.
Creative Planning first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 16 quarters.
Creative Planning's Intercept Pharmaceuticals, Inc. position peaked at $3.71M in Q1 2019.
215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.